American Bio Medica Corp (ABMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -199 | -990 | -962 | -710 | -297 |
| Depreciation Amortization | 92 | 437 | 338 | 232 | 117 |
| Accounts receivable | -143 | -53 | -753 | -242 | -12 |
| Accounts payable and accrued liabilities | 236 | 312 | 12 | -39 | 79 |
| Other Working Capital | 231 | -69 | -150 | -353 | -449 |
| Other Operating Activity | -139 | -242 | 767 | 307 | -51 |
| Operating Cash Flow | $78 | $-605 | $-748 | $-805 | $-613 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7 | -706 | -632 | -564 | -460 |
| Investing Cash Flow | $-7 | $-706 | $-632 | $-564 | $-460 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 547 | 900 | 800 | 500 |
| Debt Issued | N/A | 539 | 539 | 539 | 539 |
| Debt Repayment | -30 | -103 | -74 | -46 | -20 |
| Common Stock Issued | N/A | 23 | 23 | 23 | N/A |
| Other Financing Activity | 0 | 0 | -273 | -228 | -120 |
| Financing Cash Flow | $-30 | $1,006 | $1,115 | $1,088 | $899 |
| Beginning Cash Position | 336 | 641 | 641 | 641 | 641 |
| End Cash Position | 377 | 336 | 376 | 360 | 467 |
| Net Cash Flow | $41 | $-305 | $-265 | $-281 | $-174 |
| Free Cash Flow | |||||
| Operating Cash Flow | 78 | -605 | -748 | -805 | -613 |
| Capital Expenditure | -7 | -706 | -632 | -564 | -460 |
| Free Cash Flow | 71 | -1,311 | -1,380 | -1,369 | -1,073 |